Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05043038 · ClinicalTrials.gov registry record
Effect of Night Float Call on Sleep and Activity Patterns Among Anesthesia Residents
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 55
- Enrollment target
NCT05043038: Completed study, sponsored by Stanford University.
NCT05043038 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 55 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05043038 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 55 participants
- Enrollment target
Study Summary
With increasing awareness about physician fatigue and its effect on patient safety, residency programs are increasingly transitioning to a night float call system. In other industries, multiple night shifts in a row can cause a disruption in the circadian rhythm, sleep debt, shift work disorder, that is related to chronic medical conditions such as obesity and cardiovascular disease. We will evaluate the effect of different call structures on resident activity, sleep and self reported measures of wellness using a commercially available Fitbit device.
Primary Outcome
The investigators will compare total sleep hours per 24 hour period during a baseline week, a night float week, and a recovery week
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2019-08-01 |
| Est. Completion | 2024-08-30 |
What the finished NCT05043038 record still lists
NCT05043038 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 55 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05043038 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05043038 about?
NCT05043038 is a clinical study titled "Effect of Night Float Call on Sleep and Activity Patterns Among Anesthesia Residents". With increasing awareness about physician fatigue and its effect on patient safety, residency programs are increasingly transitioning to a night float call system. In other industries, multiple night shifts in a row can cause a disruption in the circadian rhythm, sleep debt, shift work disorder, tha...
What is the current status of trial NCT05043038?
This trial is currently completed. The enrollment target is 55 participants. The study started on 2019-08-01. Estimated completion is 2024-08-30.
Who is sponsoring clinical trial NCT05043038?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI